Variant report

Variant	rs13284363
Chromosome Location	chr9:19130712-19130713
allele	A/G
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:1)
CpG islands
(count:0)
Chromatin interactive
region (count:6)
LncRNA
region (count:1)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:1 , 50 per page) page: 1

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	SIN3A	chr9:19130616-19130816	H1-hESC	embryonic stem cell:	n/a	n/a

No data

(count:6 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr9:19128630..19131218-chr9:19137487..19139302,2	K562	blood:
2	chr9:19126615..19131871-chr9:19228040..19232542,7	MCF-7	breast:
3	chr9:19128741..19130939-chr9:19361701..19364444,2	K562	blood:
4	chr9:19126218..19128183-chr9:19129523..19131340,2	MCF-7	breast:
5	chr9:19101429..19104985-chr9:19125580..19131342,7	K562	blood:
6	chr9:19128414..19130954-chr9:19155486..19158249,2	MCF-7	breast:

(count:1 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-PLIN2-1	chr9:19129735-19131269	NONHSAT130327

No data

Variant related genes	Relation type
PLIN2	TF binding region
ENSG00000147874	Chromatin interaction
ENSG00000137145	Chromatin interaction
ENSG00000147872	Chromatin interaction

Extended variants
information (count: 14 )
Associated
traits (count: 1 )

rSNPs within LD-proxies of this variant (count:2)

rs_ID	r²[population]
rs3808657	0.80[AMR][1000 genomes];0.82[ASN][1000 genomes]
rs3824368	0.82[ASN][1000 genomes]

Variant overlapped rSNPs/rCNVs (count:12 , 50 per page) page: 1

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	nsv1017820	chr9:18882219-19587377	Strong transcription Weak transcription Enhancers Flanking Active TSS Active TSS Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Genic enhancers Bivalent/Poised TSS ZNF genes & repeats Bivalent Enhancer	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	94 gene(s)	inside rSNPs	diseases
2	nsv540078	chr9:18882219-19587377	Genic enhancers Transcr. at gene 5' and 3' Enhancers Weak transcription Strong transcription Flanking Active TSS Active TSS ZNF genes & repeats Bivalent Enhancer Flanking Bivalent TSS/Enh Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	94 gene(s)	inside rSNPs	diseases
3	nsv892700	chr9:18979441-19156784	Enhancers Flanking Active TSS Active TSS Strong transcription Genic enhancers Weak transcription Transcr. at gene 5' and 3' ZNF genes & repeats Flanking Bivalent TSS/Enh Bivalent/Poised TSS Bivalent Enhancer	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	26 gene(s)	inside rSNPs	diseases
4	nsv1028623	chr9:19034742-19394712	Strong transcription Flanking Active TSS Enhancers Weak transcription Transcr. at gene 5' and 3' ZNF genes & repeats Active TSS Flanking Bivalent TSS/Enh Genic enhancers Bivalent/Poised TSS Bivalent Enhancer	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	90 gene(s)	inside rSNPs	diseases
5	nsv540079	chr9:19034742-19394712	Weak transcription Strong transcription Flanking Active TSS Active TSS Enhancers Genic enhancers Transcr. at gene 5' and 3' ZNF genes & repeats Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	90 gene(s)	inside rSNPs	diseases
6	nsv430003	chr9:19074740-19247826	Strong transcription Enhancers Flanking Active TSS Genic enhancers Weak transcription Active TSS Transcr. at gene 5' and 3' Bivalent/Poised TSS ZNF genes & repeats Flanking Bivalent TSS/Enh Bivalent Enhancer	TF binding region CpG island Chromatin interactive region lncRNA	23 gene(s)	inside rSNPs	diseases
7	nsv870340	chr9:19077714-19143230	Genic enhancers Weak transcription Transcr. at gene 5' and 3' Strong transcription Active TSS Enhancers Flanking Active TSS Bivalent/Poised TSS ZNF genes & repeats Flanking Bivalent TSS/Enh Bivalent Enhancer	TF binding region CpG island Chromatin interactive region lncRNA	16 gene(s)	inside rSNPs	diseases
8	nsv1018947	chr9:19094894-19394712	Weak transcription Enhancers Flanking Active TSS Strong transcription Transcr. at gene 5' and 3' Active TSS ZNF genes & repeats Genic enhancers Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer	TF binding region CpG island Chromatin interactive region lncRNA	81 gene(s)	inside rSNPs	diseases
9	nsv1033552	chr9:19104662-19131866	Enhancers Flanking Active TSS Weak transcription Genic enhancers Active TSS Strong transcription Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Bivalent Enhancer Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region lncRNA	8 gene(s)	inside rSNPs	diseases
10	esv2757322	chr9:19126476-19161145	Flanking Active TSS Enhancers Active TSS Weak transcription Flanking Bivalent TSS/Enh ZNF genes & repeats Transcr. at gene 5' and 3' Bivalent/Poised TSS Bivalent Enhancer	TF binding region CpG island Chromatin interactive region lncRNA	6 gene(s)	inside rSNPs	diseases
11	esv2759676	chr9:19126476-19161145	Weak transcription Transcr. at gene 5' and 3' Enhancers Active TSS Flanking Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA	6 gene(s)	inside rSNPs	diseases
12	nsv892702	chr9:19126565-19298581	Weak transcription Active TSS Enhancers Strong transcription ZNF genes & repeats Flanking Active TSS Bivalent/Poised TSS Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Genic enhancers Bivalent Enhancer	TF binding region CpG island Chromatin interactive region lncRNA	14 gene(s)	inside rSNPs	diseases

mRNA abundance (count:1)

SNP	Gene	Cis/trans	Tissue	Source
rs13284363	ADFP	Cis_1M	lymphoblastoid	RTeQTL

Chromatin state (count:47 , 50 per page) page: 1

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr9:19128000-19132400	Enhancers	HepG2	liver
2	chr9:19128800-19130800	Enhancers	NHDF-Ad	bronchial
3	chr9:19128800-19130800	Enhancers	NHLF	lung
4	chr9:19129000-19130800	Enhancers	IMR90 fetal lung fibroblasts Cell Line	lung
5	chr9:19129000-19130800	Enhancers	Primary T cells fromperipheralblood	blood
6	chr9:19129000-19130800	Enhancers	Primary Natural Killer cells fromperipheralblood	blood
7	chr9:19129000-19130800	Enhancers	Fetal Thymus	thymus
8	chr9:19129000-19130800	Enhancers	HSMM	muscle
9	chr9:19129000-19131200	Enhancers	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
10	chr9:19129000-19132000	Weak transcription	Right Atrium	heart
11	chr9:19129200-19130800	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
12	chr9:19129200-19131000	Enhancers	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
13	chr9:19129200-19131200	Enhancers	Foreskin Keratinocyte Primary Cells skin03	Skin
14	chr9:19129200-19132000	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
15	chr9:19129200-19133200	Weak transcription	Fetal Intestine Large	intestine
16	chr9:19129400-19131000	Flanking Active TSS	HUES48 Cell Line	embryonic stem cell
17	chr9:19129400-19131000	Flanking Active TSS	HUES6 Cell Line	embryonic stem cell
18	chr9:19129400-19131200	Flanking Active TSS	iPS-20b Cell Line	embryonic stem cell
19	chr9:19129600-19130800	Enhancers	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
20	chr9:19129800-19133000	Weak transcription	Fetal Intestine Small	intestine
21	chr9:19130000-19131600	Enhancers	H1 Derived Mesenchymal Stem Cells	ES cell derived
22	chr9:19130200-19130800	Active TSS	H9 Cell Line	embryonic stem cell
23	chr9:19130200-19130800	Enhancers	Primary T cells from cord blood	blood
24	chr9:19130200-19130800	Enhancers	HUVEC	blood vessel
25	chr9:19130200-19130800	Enhancers	NH-A	brain
26	chr9:19130200-19131000	Weak transcription	Stomach Mucosa	stomach
27	chr9:19130200-19131000	Enhancers	GM12878-XiMat	blood
28	chr9:19130200-19131400	Enhancers	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
29	chr9:19130200-19132400	Enhancers	Hela-S3	cervix
30	chr9:19130200-19133000	Weak transcription	K562	blood
31	chr9:19130400-19130800	Flanking Active TSS	Foreskin Fibroblast Primary Cells skin02	Skin
32	chr9:19130400-19131000	Flanking Active TSS	ES-I3 Cell Line	embryonic stem cell
33	chr9:19130400-19131000	Flanking Active TSS	HUES64 Cell Line	embryonic stem cell
34	chr9:19130400-19131400	Enhancers	Muscle Satellite Cultured Cells	--
35	chr9:19130400-19131600	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
36	chr9:19130400-19132000	Enhancers	iPS DF 6.9 Cell Line	embryonic stem cell
37	chr9:19130400-19132200	Enhancers	H1 Cell Line	embryonic stem cell
38	chr9:19130400-19134200	Weak transcription	Monocytes-CD14+_RO01746	blood
39	chr9:19130400-19137200	Weak transcription	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
40	chr9:19130600-19130800	Enhancers	ES-WA7 Cell Line	embryonic stem cell
41	chr9:19130600-19130800	Active TSS	iPS-15b Cell Line	embryonic stem cell
42	chr9:19130600-19130800	Enhancers	Fetal Muscle Trunk	muscle
43	chr9:19130600-19130800	Enhancers	Sigmoid Colon	Sigmoid Colon
44	chr9:19130600-19130800	Enhancers	Spleen	Spleen
45	chr9:19130600-19131400	Enhancers	iPS-18 Cell Line	embryonic stem cell
46	chr9:19130600-19132200	Enhancers	Foreskin Fibroblast Primary Cells skin01	Skin
47	chr9:19130600-19133400	Weak transcription	Osteobl	bone

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links